Want to see SCL full AI Analyst Report?
Stepan Company (SCL) AI Stock Analysis
Stepan Company
(NYSE:SCL)
SCL scores as neutral-to-moderately attractive: strong technical momentum and a notably positive earnings call with cost-savings execution and improved leverage support the outlook. Offsetting this, current financial performance is still weak (very low TTM margins and negative/volatile free cash flow) and valuation is a major headwind due to the extremely elevated P/E, leaving the overall risk/reward balanced rather than compelling.
Stepan Company (SCL) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $1.54B
- Dividend Yield
- 2.33%
- Average Volume (3M)
- 145.29K
- Price to Earnings (P/E)
- 357.1
- Beta (1Y)
- 0.95
- Revenue Growth
- 10.02%
- EPS Growth
- -90.50%
- Country
- US
- Employees
- 2,328
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Chemicals - Specialty
Stepan Company Business Overview & Revenue Model
Company Description
Stepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products in the United States, France, Poland, the United Kingdom, Brazil, Mexico, and international...
How the Company Makes Money
Stepan makes money primarily by manufacturing chemical products and selling them to customers under negotiated supply agreements and purchase orders, generating revenue largely based on shipped volumes and contract/market-based pricing for each produ...
Stepan Company Earnings Call Summary
The call was strongly positive overall. Highlights significantly outweighed the challenges, with broad-based volume and earnings growth, higher margins, savings ahead of plan, improved leverage, positive free cash flow, customer expansion, and a positive full-year outlook. The main negatives were raw material and geopolitical volatility, working capital usage, restructuring and maintenance costs, weaker European and Asian demand, lower crop productivity demand, and expected moderation in fourth-quarter volume growth.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
For 2026, Stepan expects to exceed the 60% 2-year $100 million pretax savings target, with Project Catalyst savings in the $66 million to $70 million range, versus a $23 million run rate in Q3; for 2027, it expects to be ahead of $25 million on average, with savings ahead of $25 million in the second half and slightly below $25 million in the first half. The company expects lower growth in Q4, and its fixed cost base is roughly $800 million, with normal inflation of 2%-3% on that base. Pasadena utilization is in the 75%-80% range, with more tolling savings expected in the second half than the first half of next year. For 2026, the company expects full year adjusted EBITDA growth, positive free cash flow, and continued deleveraging of the balance sheet.
Stepan Company Financial Statement Overview
Summary
Financials are mixed. Income statement weakness is the key drag (TTM net margin ~0.2% and EBIT margin ~1.3% despite ~4.2% revenue growth), indicating significant profitability compression. The balance sheet is comparatively steady with manageable leverage (debt-to-equity ~0.52), but returns have fallen near zero (ROE ~0.4%). Cash flow adds risk: operating cash flow is positive (~$132M) but TTM free cash flow is negative (~-$66M) and volatile, with weak cash conversion versus EBIT.
Income Statement
44NeutralBalance Sheet
63PositiveCash Flow
38Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.53B | 2.33B | 2.18B | 2.33B | 2.77B | 2.35B |
| Gross Profit | 303.93M | 269.89M | 272.21M | 277.60M | 427.07M | 395.81M |
| EBITDA | 160.91M | 212.17M | 192.10M | 169.68M | 294.24M | 270.42M |
| Net Income | 4.32M | 46.90M | 50.37M | 40.20M | 147.15M | 137.80M |
Balance Sheet | ||||||
| Total Assets | 2.39B | 2.36B | 2.30B | 2.36B | 2.43B | 2.07B |
| Cash, Cash Equivalents and Short-Term Investments | 98.10M | 132.69M | 99.67M | 129.82M | 173.75M | 159.19M |
| Total Debt | 634.10M | 691.04M | 682.83M | 712.17M | 637.70M | 420.25M |
| Total Liabilities | 1.17B | 1.11B | 1.13B | 1.15B | 1.27B | 991.42M |
| Stockholders Equity | 1.22B | 1.24B | 1.17B | 1.22B | 1.17B | 1.07B |
Cash Flow | ||||||
| Free Cash Flow | -65.87M | 25.37M | 39.28M | -85.46M | -140.79M | -122.35M |
| Operating Cash Flow | 131.56M | 147.88M | 162.05M | 174.88M | 160.76M | 72.14M |
| Investing Cash Flow | -98.41M | -89.05M | -116.94M | -258.67M | -308.09M | -376.83M |
| Financing Cash Flow | -46.87M | -35.44M | -64.52M | 33.28M | 166.21M | 117.33M |
Stepan Company Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SCL, the sentiment is Positive. The current price of 67.85 is above the 20-day moving average (MA) of 65.15, above the 50-day MA of 63.51, and above the 200-day MA of 56.73, indicating a bullish trend. The MACD of 1.89 indicates Negative momentum. The RSI at 58.47 is Neutral, neither overbought nor oversold. The STOCH value of 59.80 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SCL.
Stepan Company Risk Analysis
Stepan Company disclosed 21 risk factors in its most recent earnings report. Stepan Company reported the most risks in the "Production" category.
Latest Risks Added
0 New RisksStepan Company Peers Comparison
Overall Rating
IOSP72Outperform
FUL68Neutral
ESI62Neutral
ASH61Neutral
SCL61Neutral
KWR60Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 72Outperform | $1.99B | 13.93 | 10.42% | 2.26% | 4.73% | ― | |
| 68Neutral | $2.83B | 13.80 | 9.51% | 1.93% | 1.48% | 72.33% | |
| 62Neutral | $8.11B | 36.39 | 7.39% | 1.04% | 39.62% | -14.83% | |
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| 61Neutral | $3.50B | 847.55 | 0.21% | 2.19% | 2.08% | ― | |
| 61Neutral | $1.61B | 357.11 | 0.36% | 2.33% | 10.02% | -90.50% | |
| 60Neutral | $2.70B | 27.14 | 7.02% | 1.35% | 8.68% | ― |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| SCL | Stepan Company | 67.85 | 25.83 | 61.46% | |
| ASH | Ashland Global Holdings, Inc. | 76.28 | 27.59 | 56.67% | |
| FUL | H.B. Fuller Company | 50.22 | -6.68 | -11.74% | |
| IOSP | Innospec | 79.13 | 3.59 | 4.75% | |
| KWR | Quaker Chemical | 152.54 | 16.55 | 12.17% | |
| ESI | Element Solutions | 30.76 | 3.36 | 12.27% |
Stepan Company Corporate Events
Stepan Company Reports Strong Q3 Results Amid Restructuring
PositiveOn October 28, 2026, Stepan reported a sharp improvement in third-quarter results, with net income rising 64% to $17.8 million and adjusted net income nearly doubling to $21.7 million as net sales climbed 17% on higher prices and stronger volumes. Ad...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 05, 2026